Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENGRUI PHARMA

72.700
+0.0500.07%
Volume:1.39M
Turnover:100.51M
Market Cap:482.51B
PE:66.39
High:73.200
Open:71.600
Low:70.600
Close:72.650
52wk High:95.200
52wk Low:52.500
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:0.94
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.095
ROE:14.34%
ROA:8.37%
PB:7.41
PE(LYR):66.39
PS:14.22

Loading ...

Executives from Alltest Biotech, OPM Biosciences, and Hengrui Pharmaceuticals Discuss: When Will China Produce a World-Class Pharmaceutical Company?

Deep News
·
Yesterday

HENGRUI PHARMA (600276.SH) Receives Clinical Trial Approval for Rezvilutamide Tablets

Stock News
·
Yesterday

AH Premium Rate and Deviation Rankings as of November 13

Stock News
·
Yesterday

HENGRUI PHARMA's Zhang Lianshan: China's Truly Global Pharma Firms Must Sell Domestic Innovations Worldwide Within 15 Years

Deep News
·
Yesterday

HK Stock Connect Shareholding Changes | Nov 13

Stock News
·
Yesterday

Jiangsu Hengrui (600276) Announces Repurchase of 150,000 A Shares

Bulletin Express
·
Nov 11

Jiangsu Hengrui (600276) Announces Share Repurchase and Updated Capital Structure

Bulletin Express
·
Nov 10

HENGRUI PHARMA (01276) Repurchases 60,000 A Shares for RMB 3.6684 Million on November 10

Stock News
·
Nov 10

AH Premium Rate and Deviation Statistics as of November 10

Stock News
·
Nov 10

HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance

Stock News
·
Nov 09

HENGRUI PHARMA: HRS-2430 Injection Receives Clinical Trial Approval Notice

Deep News
·
Nov 09

HENGRUI PHARMA (01276) Transfers 13.5111 Million Repurchased A Shares to Employee Stock Ownership Plan

Stock News
·
Nov 07

BRIEF-Citigroup's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Decreases To 4.67% On Nov 3 From 5.30% - HKEX

Reuters
·
Nov 07

Hong Kong Stock Short Interest Data as of November 7

Stock News
·
Nov 07

HENGRUI PHARMA (600276.SH): SHR-4610 Injection Receives Clinical Trial Approval

Stock News
·
Nov 07

Citigroup's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 4.67% on Nov 3 From 5.30% - HKEX

THOMSON REUTERS
·
Nov 07

AH Share Premium Rate and Deviation Rankings as of November 7

Stock News
·
Nov 07

Wellington Management Group LLP Increases Stake in Hengrui Pharma (01276) by 855,600 Shares at HK$72.6411 per Share

Stock News
·
Nov 06

Hengrui Pharma (600276) Announces Share Repurchase Update

Bulletin Express
·
Nov 04

Hengrui Pharma (01276) Announces October 2025 Share Capital and Repurchase Update

Bulletin Express
·
Nov 04